Technical Analysis for ABVC - ABVC Biopharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Calm After Storm | Range Contraction | -4.49% | |
Upper Bollinger Band Walk | Strength | -4.49% | |
Wide Bands | Range Expansion | -4.49% | |
Overbought Stochastic | Strength | -4.49% | |
Gapped Down | Weakness | -4.49% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Up 3% | 1 day ago |
Up 2% | 1 day ago |
Up 1% | 1 day ago |
Get a Trading Sidekick!
- Earnings date: 11/13/2024
ABVC Biopharma, Inc. Description
American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Pancreatic Cancer Depression Major Depressive Disorder Myelodysplastic Syndrome Attention Deficit Hyperactivity Disorder Treatment Of Pancreatic Cancer Triple Negative Breast Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.22 |
52 Week Low | 0.4053 |
Average Volume | 147,283 |
200-Day Moving Average | 0.94 |
50-Day Moving Average | 0.64 |
20-Day Moving Average | 0.60 |
10-Day Moving Average | 0.66 |
Average True Range | 0.07 |
RSI (14) | 52.83 |
ADX | 29.11 |
+DI | 24.82 |
-DI | 14.43 |
Chandelier Exit (Long, 3 ATRs) | 0.56 |
Chandelier Exit (Short, 3 ATRs) | 0.62 |
Upper Bollinger Bands | 0.77 |
Lower Bollinger Band | 0.43 |
Percent B (%b) | 0.69 |
BandWidth | 56.42 |
MACD Line | 0.02 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0165 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.79 | ||||
Resistance 3 (R3) | 0.79 | 0.76 | 0.77 | ||
Resistance 2 (R2) | 0.76 | 0.73 | 0.76 | 0.76 | |
Resistance 1 (R1) | 0.71 | 0.71 | 0.69 | 0.70 | 0.75 |
Pivot Point | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
Support 1 (S1) | 0.62 | 0.64 | 0.61 | 0.62 | 0.57 |
Support 2 (S2) | 0.59 | 0.62 | 0.59 | 0.56 | |
Support 3 (S3) | 0.54 | 0.59 | 0.55 | ||
Support 4 (S4) | 0.53 |